HLA-A*33:03:31, a novel variant of HLA-A*33:03, discovered in a Taiwanese individual

One nucleotide substitution of HLA-A*33:03:01 results in a novel allele, HLA-A*33:03:31.

Detection of a novel HLA-C*07:341 variant, HLA-C*07:341:02, in a Taiwanese hematopoietic stem cell donor

Two nucleotide replacements in codon 138 of the HLA-C*07:341:01 result in a novel allele, HLA-C*07:341:02.

HLA-A*24:333, a novel HLA-A*24 variant, discovered in a Taiwanese individual

Four nucleotide replacements of HLA-A*24:02:01:01 result in a novel allele, HLA-A*24:333.

HLA-B*46:65, a novel HLA-B*46 variant, detected in a Taiwanese unrelated bone marrow stem cell donor

One nucleotide exchange at residue 550 of the HLA-B*46:65 results in a novel allele, HLA-B*46:65.

HLA-C*07:486, a novel HLA-C*07 variant, detected in a Taiwanese individual

One nucleotide exchange at residue 812 of the HLA-C*07:02:01:01 results in a novel allele, HLA-C*07:486.

HLA-B*40:327, a novel HLA-B*40 variant, discovered in a Taiwanese blood donor

One nucleotide substitution at residue 220 of HLA-B*40:01:01 results in a new allele, HLA-B*40:327.

Identification of a novel HLA-A*02 variant, HLA-A*02:610, in a Taiwanese individual

One nucleotide substitution at residue 204 of the HLA-A*02:01:01:01 results in a new allele, HLA-A*02:610.

Discovery of HLA-B*58:77, a novel HLA-B*58 variant, in a Taiwanese blood donor

One nucleotide substitution at residue 506 of HLA-B*58:01:01:01 results in a novel allele, HLA-B*58:77.

HLA-A*24:334, a novel variant of HLA-A*24, discovered in a Taiwanese individual

One nucleotide replacement at residue 587 of HLA-A*24:02:01:01 results in a novel allele, HLA-A*24:334.

HLA-B*40:326, a novel variant of HLA-B*40, discovered in a Taiwanese blood donor

One nucleotide substitution at residue 476 of HLA-B*40:01:01 results in a new allele, HLA-B*40:326.

Discovery of HLA-B*35:307, a novel HLA-B*35 variant, in a Taiwanese hematopoietic stem cell donor

One nucleotide substitution at residue 421 of HLA-B*35:01:01:01 results in a novel allele, HLA-B*35:307.

Discovery of HLA-B*55:02:10, a novel HLA-B*55:02 variant, in a Taiwanese hematopoietic stem cell donor

One nucleotide substitution at residue 448 of HLA-B*55:02:01:01 results in a novel allele, HLA-B*55:02:10.

HLA-B*40:01:44, a novel variant of HLA-B*40:01, discovered in a Taiwanese hematopoietic stem cell donor

One nucleotide replacement at residue 147 of HLA-B*40:01:01 results in a new allele, HLA-B*40:01:44.

HLA-A*11:231, a novel variant of HLA-A*11, found in a Taiwanese hematopoietic stem cell donor

One nucleotide substitution at residue 517 of HLA-A*11:01:01:01 results in a novel allele, HLA-A*11:231.

Discovery of HLA-A*11:01:69, a novel HLA-A*11:01 variant, in a Taiwanese hematopoietic stem cell donor

One nucleotide replacement at residue 210 of HLA-A*11:01:01:01 results in a novel allele, HLA-A*11:01:69.

Detection of HLA-C*04:212, a novel HLA-C*04 variant, in a Taiwanese hematopoietic stem cell donor

Recombination and point mutation may result the formation of HLA-C*04:212.

Measurement of the Reactor Antineutrino Flux and Spectrum at Daya Bay

This Letter reports a measurement of the flux and energy spectrum of electron antineutrinos from six 2.9 GWth nuclear reactors with six detectors deployed in two near (effective baselines 512 and 561 m) and one far (1579 m) underground experimental halls in the Daya Bay experiment. Using 217 days of data, 296 721 and 41 589 inverse β decay (IBD) candidates were detected in the near and far halls, respectively. The measured IBD yield is (1.55±0.04) ×10(-18)  cm(2) GW(-1) day(-1) or (5.92±0.14) ×10(-43)  cm(2) fission(-1). This flux measurement is consistent with previous short-baseline reactor antineutrino experiments and is 0.946±0.022 (0.991±0.023) relative to the flux predicted with the Huber-Mueller (ILL-Vogel) fissile antineutrino model. The measured IBD positron energy spectrum deviates from both spectral predictions by more than 2σ over the full energy range with a local significance of up to ∼4σ between 4-6 MeV. A reactor antineutrino spectrum of IBD reactions is extracted from the measured positron energy spectrum for model-independent predictions.

A novel HLA-A*02 variant, HLA-A*02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor

One nucleotide substitution at residue 410 of HLA-A*02:07:01 results in a new allele, HLA-A*02:575.

Identification of a novel HLA-B*46:01 variant, HLA-B*46:01:20, in a Taiwanese unrelated hematopoietic stem cell donor

One nucleotide replacement at residue 528 of HLA-B*46:01:01 results in a new allele, HLA-B*46:01:20.

New measurement of antineutrino oscillation with the full detector configuration at Daya Bay

We report a new measurement of electron antineutrino disappearance using the fully constructed Daya Bay Reactor Neutrino Experiment. The final two of eight antineutrino detectors were installed in the summer of 2012. Including the 404 days of data collected from October 2012 to November 2013 resulted in a total exposure of 6.9×10^{5} GW_{th}  ton days, a 3.6 times increase over our previous results. Improvements in energy calibration limited variations between detectors to 0.2%. Removal of six ^{241}Am-^{13}C radioactive calibration sources reduced the background by a factor of 2 for the detectors in the experimental hall furthest from the reactors. Direct prediction of the antineutrino signal in the far detectors based on the measurements in the near detectors explicitly minimized the dependence of the measurement on models of reactor antineutrino emission. The uncertainties in our estimates of sin^{2}2θ_{13} and |Δm_{ee}^{2}| were halved as a result of these improvements. An analysis of the relative antineutrino rates and energy spectra between detectors gave sin^{2}2θ_{13}=0.084±0.005 and |Δm_{ee}^{2}|=(2.42±0.11)×10^{-3}  eV^{2} in the three-neutrino framework.

HLA-DRB1*14:84 may have been derived from HLA-DRB1*14:05 and HLA-DRB1*04:58 via a genetic recombination event

Derivation of HLA-DRB1*14:84 via a genetic recombination event.

Detection of a novel variant of HLA-B*07, HLA-B*07:249, in a Taiwanese unrelated hematopoietic stem cell donor

One nucleotide replacement at residue 398 of HLA-B*07:05:01 or HLA-B*07:06 results in a novel allele, HLA-B*07:249.

Detection of a novel HLA-B*15 variant, HLA-B*15:01:37, in a Taiwanese unrelated hematopoietic stem cell donor

One nucleotide substitution at residue 531 of HLA-B*15:01:01:01 results in a new allele, HLA-B*15:01:37.

A single nucleotide replacement in exon 2 produces a novel HLA-C*01:02 variant, HLA-C*01:02:34

HLA-C*01:02:34 differs from HLA-C*01:02:01 by a single nucleotide replacement in codon 43.

HLA-B*15:327, a novel variant of HLA-B*15, discovered in a Taiwanese unrelated hematopoietic stem cell donor

One nucleotide substitution at residue 86 of HLA-B*15:27:01 results in a new allele, HLA-B*15:327.